Teiji Kuzuya

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Gut · 2019 · 686 citations · Full text

Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†

Yasuhiro Asahina, Kaoru Tsuchiya, Nobuharu Tamaki et al. · Hepatology · 2010 · 296 citations · Full text

FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma

Tokuzo Arao, Kazuomi Ueshima, Tomoyuki Nagai et al. · Hepatology · 2012 · 152 citations · Full text

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus‐related hepatocellular carcinoma

Teiji Kuzuya, Yoshiaki Katano, Takashi Kumada et al. · Journal of Gastroenterology and Hepatology · 2006 · 123 citations

Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Liver Cancer · 2022 · 118 citations · Full text